This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Aetna Arm Secures Contract for its Kansas Medicaid Program
by Zacks Equity Research
The State of Kansas awards Medicaid managed care contract to a subsidiary of Aetna (AET) for providing better health care to the Medicaid members.
Walgreens-GE Faceoff: How Impactful is it for Dow Investors?
by Urmimala Biswas
The stock performance of Walgreens Boots (WBA) currently does not offer much conviction. Over the past year, shares show a decline of 17.9%.
Will Amazon's Entry Into Healthcare Disrupt the Market?
by Sapna Bagaria
Appointment of a CEO for the healthcare alliance of Amazon, Berkshire Hathaway and JP Morgan marks invasion in the space.
Humana, Walgreens Team Up to Provide Better Senior Care
by Zacks Equity Research
Humana (HUM) ties up with Walgreens to provide better primary care and other services to seniors of the Kansas City Community.
Anthem Boosts Integrated Care With Aspire Health Buyout
by Zacks Equity Research
Anthem's (ANTM) acquisition of Aspire Health points to its increased efforts in comprehensive community-based palliative care space.
What Makes UnitedHealth (UNH) Stand Out in Its Industry?
by Zacks Equity Research
UnitedHealth (UNH) stands out by virtue of its immense scale and size.
UnitedHealth (UNH) Hits 52-Week High: Is More Upside Left?
by Zacks Equity Research
UnitedHealth (UNH) hits 52-week high on dividend hike, share buyback renewal, and agreements with lab and diagnostic companies.
Why Centene (CNC) Stock More Than Doubled its Industry YTD
by Zacks Equity Research
Centene (CNC) stock surges on the back of successive Medicaid contract awards and a slew of acquisitions.
LabCorp, Unilabs Tie Up to Expand in Companion Diagnostics
by Zacks Equity Research
LabCorp (LH) continues to strengthen hold in the diagnostics space through inorganic means.
Morgan Stanley Calls Labs 'Safe Havens': Stocks to Watch
by Sweta Jaiswal
With Morgan Stanley calling clinical laboratory services market a safe haven, let's find out what's working in favor and against this burgeoning niche market.
LabCorp Extends Aetna Agreement, Expands Diagnostics Business
by Zacks Equity Research
The expanded agreement enables LabCorp (LH) to serve as a preferred national laboratory to almost all of Aetna's members starting Jan 1, 2019.
Aetna (AET) Down 1.1% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Aetna (AET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WellCare to Consolidate Medicaid With Meridian Health Plans
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) announces that it will acquire Meridian Health Plans of Michigan and Illinois and MeridianRx for a total of $2.5 billion.
UnitedHealth Extends LabCorp Ties, Signs Quest Diagnostic Deal
by Zacks Equity Research
UnitedHealth (UNH) agrees with laboratories and diagnostic companies for value based care.
Anthem to Buy Aspire Health for Better Healthcare Service
by Zacks Equity Research
Anthem (ANTM) agrees to take over Aspire Health for providing better and integrated medical care outside hospital.
Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana
Envision Healthcare (EVHC) Q1 Earnings Beat, Revenues Rise
by Zacks Equity Research
Envision Healthcare's (EVHC) Q1 earnings gain from by revenue growth at its Physicians Services segment.
Cigna Q1 Earnings Top on Higher Enrollment, 2018 View Up
by Zacks Equity Research
Cigna (CI) Q1 earnings gain from an increase in membership and revenue growth.
Acadia Healthcare (ACHC) Beats on Q1 Earnings and Revenues
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q1 earnings beat on revenue growth led by the addition of beds, partly offset by an increase in expenses.
Teladoc (TDOC) Loss Lower Than Expected, '18 View Intact
by Zacks Equity Research
Teladoc (TDOC) Q1 results showed an increase in revenues led by higher visits and membership.
Aetna (AET) Q1 Earnings Beat Estimates, Enrollment Declines
by Zacks Equity Research
Bottom-line growth and higher adjusted revenues in Health Care segment aid Aetna's (AET) first-quarter results. However, lower enrollment plays a spoilsport.
Aetna (AET) Q1 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
Bottom-line growth, higher expenses ratio and lower revenues find reflections in Aetna's (AET) Q1 earnings.
Humana (HUM) Q1 Earnings to Benefit From Medicare Business
by Zacks Equity Research
Humana (HUM) Q1 earnings should see upside from higher revenues in Retail segment, but investments may increase total expenses.
Will Teladoc (TDOC) Q1 Earnings Buoy On Severe Flu Season?
by Zacks Equity Research
We expect Teladoc's (TDOC) earnings to see an upside from the recent severe flu season,which should lead to higher patient visits.
Healthcare Q1 Earnings Due on May 1: AET, HCA, WCG, ACHC
by Zacks Equity Research
Severe flu season, higher enrollment in government plans and cost containment may affect Q1 earnings of Healthcare stocks.